131 related articles for article (PubMed ID: 16883270)
1. [Pharmacogenetics of indirect anticoagulants: value of genotype for improvement of efficacy and safety of therapy].
Sychov DA; Kropacheva ES; Ignat'ev IV; Bulytova IuM; Dobrovol'skiĭ AB; Panchenko EP; Kukes VG
Kardiologiia; 2006; 46(7):72-7. PubMed ID: 16883270
[TBL] [Abstract][Full Text] [Related]
2. Dynamic pharmacogenetic models in anticoagulation therapy.
Bon Homme M; Reynolds KK; Valdes R; Linder MW
Clin Lab Med; 2008 Dec; 28(4):539-52. PubMed ID: 19059061
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of acenocoumarol: CYP2C9 *2 and VKORC1 c.-1639G>A, 497C>G, 1173C>T, and 3730G>A variants influence drug dose in anticoagulated patients.
Verde Z; Santiago C; Valle B; Fernández-Santander A; Bandrés F; Calvo E; Ruiz JR; Lucía A; Gallego FG
Thromb Haemost; 2009 Mar; 101(3):591-3. PubMed ID: 19277427
[No Abstract] [Full Text] [Related]
4. Refining the use of warfarin through genetic testing.
Lee SC
Int Angiol; 2008 Aug; 27(4):271-3. PubMed ID: 18677287
[No Abstract] [Full Text] [Related]
5. Pathology consultation on warfarin pharmacogenetic testing.
Stack G;
Am J Clin Pathol; 2011 Jan; 135(1):13-9. PubMed ID: 21173120
[No Abstract] [Full Text] [Related]
6. [Pharmacogenetics of oral anticoagulants: individualized drug treatment for more efficacy and safety].
Loriot MA; Beaune P
Rev Prat; 2007 Jun; 57(12):1281-6. PubMed ID: 17717937
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomic considerations for customizing warfarin therapy in the orthopedic patient.
Rhee S; Walsh K; Lewis D; Davis G; Smith KM
Orthopedics; 2010 Nov; 33(11):828. PubMed ID: 21053849
[No Abstract] [Full Text] [Related]
8. [Pharmacogenetics of warfarin].
Kessler P
Vnitr Lek; 2006 Mar; 52 Suppl 1():31-4. PubMed ID: 16637447
[TBL] [Abstract][Full Text] [Related]
9. Genotype and adverse drug reactions to warfarin.
Byron KA; Dear AE
Med J Aust; 2007 Jul; 187(1):61-2. PubMed ID: 17605718
[No Abstract] [Full Text] [Related]
10. Pharmacogenetic-based dosing of warfarin.
Med Lett Drugs Ther; 2008 May; 50(1286):39-40. PubMed ID: 18487958
[No Abstract] [Full Text] [Related]
11. Pharmacogenetic differences between warfarin, acenocoumarol and phenprocoumon.
Beinema M; Brouwers JR; Schalekamp T; Wilffert B
Thromb Haemost; 2008 Dec; 100(6):1052-7. PubMed ID: 19132230
[TBL] [Abstract][Full Text] [Related]
12. Genetic testing for warfarin dosing? Not yet ready for prime time.
Bussey HI; Wittkowsky AK; Hylek EM; Walker MB
Pharmacotherapy; 2008 Feb; 28(2):141-3. PubMed ID: 18225960
[No Abstract] [Full Text] [Related]
13. Warfarin pharmacogenetics: ready for clinical utility?
Baudhuin LM
Clin Lab Sci; 2009; 22(3):151-5. PubMed ID: 19827409
[No Abstract] [Full Text] [Related]
14. Pharmacogenetics of coumarinic oral anticoagulants.
Manolopoulos VG; Ragia G; Tavridou A
Pharmacogenomics; 2010 Apr; 11(4):493-6. PubMed ID: 20350128
[TBL] [Abstract][Full Text] [Related]
15. [Application of warfarin pharmacogenetics].
Tomek A; Mat'oska V; Kumstýrfová T; Táborský L
Vnitr Lek; 2009 Jun; 55(6):565-9. PubMed ID: 19662888
[TBL] [Abstract][Full Text] [Related]
16. The long and winding road to warfarin pharmacogenetic testing.
Ginsburg GS; Voora D
J Am Coll Cardiol; 2010 Jun; 55(25):2813-5. PubMed ID: 20579536
[No Abstract] [Full Text] [Related]
17. VKORC1 and CYP2C9 genotypes and acenocoumarol anticoagulation status: interaction between both genotypes affects overanticoagulation.
Schalekamp T; Brassé BP; Roijers JF; Chahid Y; van Geest-Daalderop JH; de Vries-Goldschmeding H; van Wijk EM; Egberts AC; de Boer A
Clin Pharmacol Ther; 2006 Jul; 80(1):13-22. PubMed ID: 16815313
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of CYP2C9 and VKORC1 alleles in the Argentine population and implications for prescribing dosages of anticoagulants.
Scibona P; Redal MA; Garfi LG; Arbelbide J; Argibay PF; Belloso WH
Genet Mol Res; 2012 Jan; 11(1):70-6. PubMed ID: 22290467
[TBL] [Abstract][Full Text] [Related]
19. Prediction of warfarin dose: why, when and how?
Eriksson N; Wadelius M
Pharmacogenomics; 2012 Mar; 13(4):429-40. PubMed ID: 22379999
[TBL] [Abstract][Full Text] [Related]
20. [Oral anticoagulation and pharmacogenetics: importance in the clinical setting].
Benusiglio PR; Desmeules J; de Moerloose P; Dayer P
Rev Med Suisse; 2007 Sep; 3(124):2030, 2033-4, 2036. PubMed ID: 17955831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
